• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: C2 THERAPEUTICS, INC. C2 CRYOBALLOON FOCAL ABLATION SYSTEM; CRYOSURGICAL UNIT AND ACCESSORIES

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

C2 THERAPEUTICS, INC. C2 CRYOBALLOON FOCAL ABLATION SYSTEM; CRYOSURGICAL UNIT AND ACCESSORIES Back to Search Results
Model Number FG-1012, FG-1009
Device Problems Adverse Event Without Identified Device or Use Problem (2993); No Apparent Adverse Event (3189)
Patient Problems Abdominal Pain (1685); Dysphagia/ Odynophagia (1815); Pleural Effusion (2010); Stenosis (2263)
Event Date 04/03/2017
Event Type  Injury  
Manufacturer Narrative
The device was not returned to the manufacturer, and further investigation could not be conducted.There were no performance issues identified for the device during the procedure.The event appears to be unrelated to the device performance.
 
Event Description
The patient was treated with cryoablation on (b)(6) using the c2 cryoballoon focal ablation system.He had long segment high grade dysplasia, and the doctor performed 26 ablations.The post procedure pain score was 10, and he was already on narcotics for a previous condition.During the holidays, the patient went to his local emergency department complaining of pain and difficulty swallowing but was not scoped.He also had abdominal issues that may have been pre-existing.The patient is on a pureed diet.
 
Manufacturer Narrative
This is follow-up report for the mdr reference: (b)(4).A commercial patient was originally treated on (b)(6) 2016.The physician planned a follow up cryoballoon procedure on (b)(6) 2017.During the follow up on (b)(6) 2017 there was a stricture noticed; the patient was dilated.The patient was also treated with the cryoballoon the same day in another area.No issue with this procedure was recorded.Stricture requiring treatment is an anticipated adverse event after endoscope ablation therapy.Therefore, this stricture requiring treatment is likely related to the procedure.Patient responded well to treatment of stricture.No report of complications or sequelae.Per request from fda on 26mar2020, supplemental report was submitted with incorrect report number.This report is being submitted to correct the report number from 3008780143-2017-00006 to 3008780134-2017-0001 follow up #1 note: the following codes on previous follow-up no longer available.3263-actual device not evaluated.3332-quality control review.3372-analysis of data log(s).
 
Event Description
The follow-up report for the mdr reference: (b)(4).A commercial patient was originally treated on (b)(6) 2016.The physician planned a follow up cryoballoon procedure on (b)(6) 2017.During the follow up on (b)(6) 2017 there was a stricture noticed; the patient was dilated.The patient was also treated with the cryoballoon the same day in another area.No issue with this procedure was recorded.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
C2 CRYOBALLOON FOCAL ABLATION SYSTEM
Type of Device
CRYOSURGICAL UNIT AND ACCESSORIES
Manufacturer (Section D)
C2 THERAPEUTICS, INC.
303 convention way
suite 1
redwood city CA 94063
MDR Report Key6257455
MDR Text Key64963605
Report Number3008780134-2017-00001
Device Sequence Number1
Product Code GEH
Combination Product (y/n)N
PMA/PMN Number
K161202
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Type of Report Initial,Followup
Report Date 04/04/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Model NumberFG-1012, FG-1009
Device Catalogue NumberFG-1012, FG-1009
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 01/04/2017
Initial Date FDA Received01/17/2017
Supplement Dates Manufacturer Received04/04/2017
Supplement Dates FDA Received04/03/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-